학술논문

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation
Document Type
Article
Source
In: Nature Communications. (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723